Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $164,368 - $220,627
2,031 New
2,031 $210,000
Q3 2020

Nov 12, 2020

SELL
$71.87 - $131.03 $132,887 - $242,274
-1,849 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$79.55 - $124.22 $147,087 - $229,682
1,849 New
1,849 $228,000
Q4 2018

Feb 06, 2019

SELL
$80.14 - $106.07 $180,795 - $239,293
-2,256 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$76.01 - $99.03 $171,478 - $223,411
2,256 New
2,256 $213,000
Q4 2017

Jan 26, 2018

SELL
$80.76 - $95.13 $184,536 - $217,372
-2,285 Closed
0 $0
Q3 2017

Oct 11, 2017

BUY
$80.6 - $94.95 $184,171 - $216,960
2,285
2,285 $213,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.